Turning Digital Validation into Real Project Value
How electronic validation is improving delivery across Life Sciences projects
Electronic validation (EVal) is reshaping how validation is delivered in pharmaceutical and biotechnology environments.
Instead of relying on fragmented, paper-based processes, organisations are now using digital validation platforms to manage commissioning, qualification and validation (CQV) activities with greater speed and control.
Moving beyond paper-based validation
Many validation programmes still rely on manual documentation, multiple handoffs and disconnected systems. These approaches can slow progress, create duplication and reduce visibility across teams.
In practice, EVal replaces these inefficiencies with a connected digital environment. Test scripts, approvals and records are managed within a single platform. Teams can see progress clearly, reduce delays and keep activities aligned with project timelines.
"“We’ve partnered with Kneat because life sciences teams need validation that moves at the pace of their projects."
"By combining our CQV expertise with Kneat’s digital validation platform, clients can reduce the delays that come with manual, paper-based processes. It also supports stronger traceability and audit readiness, because records are managed digitally with clear oversight. In short - it’s a practical way to make validation easier to run, and easier to keep on track,” said Mike Sweeney, CQV EVal Lead, PM Group.
Embedding efficiency into the validation lifecycle
EVal enables a more streamlined approach to the full CQV lifecycle. Digital workflows remove repetitive tasks, simplify document management and support faster execution of validation activities.
Standard templates and structured processes help create consistency across projects and locations. This improves predictability and supports a more reliable delivery model, particularly for global programmes.
“ A key advantage of EVal is access to real-time information. Project teams and quality stakeholders can monitor progress, identify risks early and respond before issues escalate."
Michael Sweeney
CQV EVal Lead
"This level of visibility supports more informed decision-making and helps keep validation aligned with wider project delivery milestones".
The impact for Life Sciences organisations
EVal is not simply a technology shift. It is a practical improvement in how validation is planned, executed and managed.
For organisations delivering complex capital projects, this translates into:
- Faster validation timelines and reduced manual effort
- Improved data integrity and audit readiness
- Greater consistency across sites and teams
- Enhanced control over the CQV lifecycle
- A scalable approach to digital validation delivery
Contact our team to learn more.
